Estrella Immunopharma Inc. (ESLA) — Tangible Net Worth Ratio
Estrella Immunopharma Inc. (ESLA) has a Tangible Net Worth Ratio of 100.0% as of December 2024. This metric is calculated by deducting intangible assets ($0.00) from net assets ($143.73K) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore net asset growth rate of Estrella Immunopharma Inc. to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Estrella Immunopharma Inc. Tangible Net Worth Ratio (2022–2024)
This chart shows how Estrella Immunopharma Inc.'s Tangible Net Worth Ratio has changed across 3 annual periods from 2022 to 2024. As of December 2024, the ratio stands at 100.0%, reflecting net assets of $143.73K with intangible assets of $0.00 USD. For live market cap and overall valuation, see ESLA stock market capitalisation.
Annual Tangible Net Worth Ratio for Estrella Immunopharma Inc. (2022–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Estrella Immunopharma Inc. from 2022 to 2024, covering 3 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. See Estrella Immunopharma Inc. free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 100.0% | $143.73K | $0.00 | $3.14 Million | ▲ +0.0 pp |
| 2023 | 100.0% | $4.27 Million | $0.00 | $4.45 Million | ▲ +0.0 pp |
| 2022 | 100.0% | $7.07 Million | $0.00 | $9.99 Million | — |